Vision Talk with World-Renowned Eye Expert Dr. Lai
Taiwanese F&B Franchise Brand Entering America Webinar
Digital Transformation in Chain Restaurant Ecosystem Forum
2021 Content Tokyo
Taiwan Healthcare Industry Seminar
2021 TAITRA Service Industry Promotion Center Events
All-in-One Cold Chain Service Successfully Landed in Vietnam
Food & Beverage Franchises
Online Boutique for Creative Design Products
Taiwan health Pavilion
TAIWAN Global Anti-COVID-19 Pavilion
2021 One-on-One Employment Meetings in Taipei 2021/10/06 ~ 2021/10/06
2021 One-on-One Employment Meetings in Tainan 2021/09/24 ~ 2021/09/24
Taiwan-Philippines Regenerative Medicine and Epidemic Prevention Online Conference 2021/09/22 ~ 2021/09/22
Healthcare Industry Online Networking between Taiwan and Southeast Asia 2021/09/15 ~ 2021/09/15
M&O 2021 2021/09/09 ~ 2021/09/13
Taiwan Original IP Ecosystem 2021/08/19 ~ 2021/08/20
Taiwan Healthcare Pavilion at TAIWAN EXPO 2021 in Vietnam virtual exhibition 2021/07/21 ~ 2021/07/23
On-Line Trade Mission of Japan:New Normal Life Business Opportunities in Design Products 2021/07/16 ~ 2021/07/16
OO Biotechnology Co., Ltd.Due to the raging COVID-19 epidemic and the shortage of medicines in Brazil, in March 2021, the Department of Latin American and Caribbean Affairs, MOFA, R.O.C reported the medicinal needs from the Commercial Office of Brazil in Taipei to inquire about products such as muscle relaxants, sedatives, anesthetics, and pain relievers.
TAITRA then cooperated with the Medical and Pharmaceutical Industry Technology and Development Center to facilitate a sedatives and anesthetic drug procurement case between the OO Company and Brazilian hospitals.
OO has a wide range of new drug development capabilities and experience: from raw material drug production to human clinical trials; from drug screening to US FDA new drug approval. As the developmental environment for new drugs in Taiwan has matured, OO companies have gradually transferred certain self-executed tasks (such as drug synthesis, biochemical analysis, and human PK testing) to outsourced execution. OO's extensive new drug development technology and experience have become important competitive advantages in drug development. It can develop various types of drugs, including the most difficult and complex new drugs with cutting-edge ingredients, medicines with improved dosage forms, new treatments with sustained-release dosage forms, and specialty generic drugs. Another advantage of the OO company is that it has executed quite a few government plans and has established advanced project execution and project management capabilities.
Grand Opening of OO Tea USA in Fremont, San FranciscoOO Food Limited Company’s brand is called OO Tea in USA. It was launched in 1999, offering tea, hand-made boba and having successfully consulted over 500 franchise stores in past 20 years in Taiwan. Its boba and milk tea quickly attained fame for their natural ingredients and smooth tastes. Other than their staple Heineken Green Tea, with a historical record of 2.5 million cups of Heineken green tea in 6 months in the year 2005.
Hand-made boba was promoted at the Franchising & Licensing Asia 2019 held by TAITRA in Singapore from October 24-26, 2019. In 2020, another OO Tea is set to open in Indonesia, offering unique products that are in great vogue among young generations. The professional team of OO Food Limited company has also joined the 2019 and 2020 Franchising & Business Opportunities Expo, and 2021 International Franchise Business Day - B2B Online Meetings held by TAITRA.